Acurx Pharmaceuticals, Inc. — Director's Dealing 2021

Nov 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Acurx Pharmaceuticals, Inc. (ACXP)
CIK: 0001736243
Period of Report: 2021-11-19

Reporting Person: LUCI DAVID P (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-19	Common Stock	P	5200	$4.80	Acquired	1008723	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15083	Indirect
Common Stock	35000	Indirect